Abstract

COVID19, as it designated by WHO, infection outbreak is constitute a real disaster worldwide, from December 2019 to April 2020, the number of affected individuals is more than the million victims. This short review aimed to gather information in the form of answering important questions in the context of Saliva in relation to COVID19 Which is caused by SARS-CoV2, as an emergent infection with limited information about. These questions are: is saliva just an environment facilitates the viral transmission?, How the saliva gets infected with corona virus? what is the actual role of the ACE2 receptors express in the oral cavity in the context of the pathogenesis of COVID-19 disease? What is the life span of the virus in saliva? and What is the role of antiviral components of saliva in combating of the coronavirus?

Keywords: Corona Virus; Saliva-ACE2-Antiviral; COVID19

References

1. who.int›who-rights-roles-respon-hw-covid-19
2. Chloé Geller., et al. “Human Coronaviruses: Insights into Environmental Resistance and Its Influence on the Development of New Antiseptic Strategies”. Viruses 4 (2012): 3044-3068.
3. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200211-sitrep-22-ncov.pdf?sfvrsn=fb6d49b1_2
4. Hussin A Rothan and Siddappa N Byrareddy. “The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak”. Journal of Autoimmunity 109 (2020): 102433
5. Likelihood of survival of coronavirus disease 2019.
6. Guan W-jie., et al. “Comorbidity and its impact on 1590 patients with Covid-19 in China: A Nationwide Analysis”. European Respiratory Journal (2020).
7. Backer Jantien A., et al. “Incubation period of 2019 novel coronavirus (2019-nCoV) infections among travellers from Wuhan, China, 20-28 January 2020”. Eurosurveillance5 (2020): pii=2000062.
8. Xiao-Wei Xu., et al. “Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series”. BMJ 368 (2020): m606.
9. Backer JA., et al. “Incubation period of 2019 novel coronavirus (2019-nCoV) infections among travellers from Wuhan, China, 20-28 January 2020”. Eurosurveillance5 (2020).
10. Fouchier RA., et al. “A previously undescribed coronavirus associated with respiratory disease in humans”. Proceedings of the National Academy of Sciences of the United States of America 101 (2004): 6212-6216.
11. LAWRENCE S., et al. “Conformational Change of the Coronavirus Peplomer Glycoprotein”. Journal of Virology 6 (1990): 3042-3050.
12. Benn A M L and Thomson W M. “Saliva: an overview”. New Zealand Dental Journal 9 (2014): 92-96.
13. Sue P Humphrey., et al. “A review of saliva: Normal composition, flow, and function”. Journal of Prosthetic Dentistry 85 (2001): 162-169.
14. M Villiger., et al. “Evaluation and review of body fluids saliva, sweat and tear compared to biochemical hydration assessment markers within blood and urine”. European Journal of Clinical Nutrition 72 (2018): 69-76.
15. Ben-Aryeh H., et al. “Composition of whole unstimulated saliva of healthy children: changes with age”. Archives of Oral Biology 35 (1990): 929-931.
16. Edgar WM. “Saliva: its secretion, composition and functions”. British Dental Journal 172 (1992): 305-312.
17. Gabriela Iorgulescu. “Saliva between normal and pathological. Important factors in determining systemic and oral health”. Journal of Medicine and Life3 (2009): 303-307.
18. To KK., et al. “Additional molecular testing of saliva specimens improves the detection of respiratory viruses”. Emergency Microbes Infection 6 (2017): e49.
19. To KKW., et al. “Saliva as a diagnostic specimen for testing respiratory virus by a point-of-care molecular assay: a diagnostic validity study”. Clinical Microbiology Infection 25 (2019): 372-378.
20. To KK., et al. “Additional molecular testing of saliva specimens improves the detection of respiratory viruses”. Emergency Microbes Infection 6 (2017): e49.
21. Li P., et al. “Transmission of COVID-19 in the terminal stage of incubation period: a familial cluster”. International Journal of Infectious Diseases (2020).
22. Robinson Sabino-Silva. “Coronavirus COVID-19 impacts to dentistry and potential salivary diagnosis”. Clinical Oral Investigations (2020).
23. To KKW., et al. “Consistent Detection of 2019 Novel Coronavirus in Saliva”. Clinical Infection Disease (2020).
24. Kelvin Kai-Wang To., et al. “Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study”. The Lancet (2020).
25. Joan L Robinson., et al. “Use of Throat Swab or Saliva Specimens for Detection of Respiratory Viruses in Children”. Clinical Infectious Diseases 46 (2008): 61e-64e.
26. Jorma Tonovuo. “Antimicrobial function of human saliva - how important is it for oral health?” Acta Odontologica Scandinavica 7 (2009): 250-256.
27. Patricia Del Vigna de Almeida., et al. “Saliva Composition and Functions: A Comprehensive Review”. The Journal of Contemporary Dental Practice 9 (2008).
28. C Dawes AML., et al. “The functions of human saliva: A review sponsored by the World Workshop on Oral Medicine”. Archives of Oral Biology 60 (2015): 863-874.
29. MR White., et al. “Multiple components contribute to ability of saliva to inhibit influenza viruses”. Oral Microbiology Immunology 24 (2009): 18-24.
30. Kashi Raj Bhattaral., et al. “Compliance with Saliva Collection Protocol in Healthy Volunteers: Strategies for Managing Risk and Errors”. International Journal of Medical Sciences 8 (2018): 823-831.
31. Rudney JD. “Does variability in salivary protein concentrations influence, oral microbial ecology and oral health?” Critical Reviews in Oral Biology and Medicine 6 (1995): 343-367.
32. D Malamud., et al. “Antiviral activity of Human Saliva”. Advances in Dental Research1 (2011): 34-37.
33. Zhang H., et al. “The digestive system is a potential route of 2019-nCov infection: a bioinformatics analysis based on single-cell transcriptomes”. bioRxiv (2020).
34. Hamming I., et al. “Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis”. Journal of Pathology 203 (2004): 631-637.
35. Donoghue M., et al. “A novel angiotensin-converting enzyme-related carboxypepti- dase (ACE2) converts angiotensin I to angiotensin 1-9”. Circulation Research 87 (2000): e1-e9.
36. Harmer D., et al. “Quantitative mRNA expression profiling of ACE 2, a novel homologue of angiotensin converting enzyme”. FEBS Letter 532 (2002): 107-110.
37. Anthony J Turner. “Chapter 25, ACE2 Cell Biology, Regulation, and Physiological Functions”. The Protective Arm of the Renin-Angiotensin System (RAS) (2015): 185-189.
38. Chih-Fong Chou., et al. “ACE2 orthologues in non-mammalian vertebrates, (Danio, Gallus, Fugu, Tetraodon and Xenopus)”. Gene 377 (2006): 46-55.
39. Y Wan., et al. “Receptor recognition by novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS”. Journal of Virology (2020).
40. Čivljak., et al. “The third coronavirus epidemic in the third millennium: what’s next?” Croatian Medical Journal 61 (2020): 1-4.
41. Zihao y. “The diverse of Ace2 receptor made the inference of host difficult. copy.pdf. figshare. Preprint” (2020).
42. Hao Xu., et al. “High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa”. International Journal of Oral Science 12 (2020): 8.
43. Roujian Lu., et al. “Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding”. Lancet10224 (2020): 565-574.

Citation

Citation: Manal Abdalla Eltahir. “Saliva: In Relation to COVID19". Acta Scientific Dental Sciences 4.8 (2020): 23-28.

Copyright

Copyright: © 2020 Manal Abdalla Eltahir. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.